PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40126P00197Nova bioprofile flex 2 operational parts — Nova Biomedical Corp

Nova Biomedical Corp holds $2.5M across 67 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 3 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. Recompete timing centers on the Sep 10, 2027 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs
Awarding office
Nova Biomedical Corp
Recipient
Sep 10, 2027
PoP end
$131K
Obligated
$131K
Potential
334516
NAICS
6640
PSC
Unrestricted
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number75F40126P00197
AgencyFda Office Of Acq Grant Svcs
Awarding officeFda Office Of Acq Grant Svcs
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentNova Biomedical Corp
CAGE1JU03
UEILCFDHTGXB5J3
NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6640
Place of performanceSILVER SPRING MD
Pricing typeFirm Fixed Price
Extent competedCompeted Under SAP
PoP startSep 11, 2026
PoP end (current)Sep 10, 2027
Obligated$131K
Current value$131K
Potential value$131K

Nova Bioprofile Flex 2 Operational Parts and Components for Three Currently Owned Nova Bioprofile Flex 2 Instruments Du… is a federal Unrestricted award for Fda Office Of Acq Grant Svcs held by Nova Biomedical Corp. Estimated value $131K ($131K obligated). Current period of performance ends Sep 10, 2027. Last award drew 1 bidder. Place of performance: SILVER SPRING MD.

Nova bioprofile flex 2 operational parts and components for three currently owned nova bioprofile flex 2 instruments due to continuing work on upstream biomanufacturing research.

Recompete timing

Public
● Expiring in 328 days

Current PoP ends Sep 10, 2027 (328 days remaining). Agencies typically plan 12–18 months ahead — at 10.8 months out, that window is already open. The buying decision is likely already in motion.

Want the durability read on 75F40126P00197? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Nova Biomedical Corp — $2.5M obligated across 67 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($2.5M) · all agencies · Top 4 shown (90%); remaining ~10% is other agencies.
Department of Veterans Affairs (VA)$750K · 30%Department of Defense (DOD)$703K · 28%Department of Health and Human Services (HHS)$529K · 21%Department of State (DOS)$257K · 10%
Open full company profile →

Related awards

Same incumbent
36C26123P0034
EXERCISING OPTION YEAR 3: STATSTRIP GLUCOSE STRIPS
$146K
Sep 30, 2027
HT941023P0014
STATSTRIP GLUCOSE METER WITH 45 STATSTRIP GLUCOSE STRIPS DELIVERY.
$155K
Jan 17, 2028
1333ND24PNB640498
PURCHASE OF MAMMALIAN CELL CULTURE METABOLITE AND CELL COUNT ANALYSIS SYSTEM WITH EXTENDED…
$150K
Apr 10, 2028

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75F40126P00197?

75F40126P00197 (Nova bioprofile flex 2 operational parts) is a Fda Office Of Acq Grant Svcs award with a potential value of $131K, currently held by Nova Biomedical Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40126P00197?

Fda Office Of Acq Grant Svcs awarded 75F40126P00197 to Nova Biomedical Corp (potential $131K).

Who is the incumbent on 75F40126P00197?

Nova Biomedical Corp is the incumbent with $2.5M across 67 related awards in SCOUT’s public footprint. The current period of performance ends Sep 10, 2027.

When does Nova Biomedical Corp’s 75F40126P00197 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 10, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75F40126P00197? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40126P00197